These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. Patt DA; Duan Z; Fang S; Hortobagyi GN; Giordano SH J Clin Oncol; 2007 Sep; 25(25):3871-6. PubMed ID: 17664457 [TBL] [Abstract][Full Text] [Related]
5. Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide. Praga C; Bergh J; Bliss J; Bonneterre J; Cesana B; Coombes RC; Fargeot P; Folin A; Fumoleau P; Giuliani R; Kerbrat P; Hery M; Nilsson J; Onida F; Piccart M; Shepherd L; Therasse P; Wils J; Rogers D J Clin Oncol; 2005 Jun; 23(18):4179-91. PubMed ID: 15961765 [TBL] [Abstract][Full Text] [Related]
6. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ; Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269 [TBL] [Abstract][Full Text] [Related]
7. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056 [TBL] [Abstract][Full Text] [Related]
8. Increased risk of acute myeloid leukaemia after treatment for breast cancer. Renella R; Verkooijen HM; Fioretta G; Vlastos G; Kurtz J; Sappino AP; Schäfer P; Neyroud-Caspar I; Bouchardy C Breast; 2006 Oct; 15(5):614-9. PubMed ID: 16386906 [TBL] [Abstract][Full Text] [Related]
9. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia. Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727 [TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members. Padmanabhan A; Baker JA; Zirpoli G; Sait SN; Ford LA; Moysich KB; Baer MR Leuk Res; 2008 Dec; 32(12):1820-3. PubMed ID: 18468682 [TBL] [Abstract][Full Text] [Related]
11. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience. Smith RE Clin Breast Cancer; 2003 Oct; 4(4):273-9. PubMed ID: 14651772 [TBL] [Abstract][Full Text] [Related]
12. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019 [TBL] [Abstract][Full Text] [Related]
13. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120 [TBL] [Abstract][Full Text] [Related]
14. Leukemia incidence following primary breast carcinoma treatment. Kaplan HG; Malmgren JA; Atwood M Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478 [TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. Smith RE; Bryant J; DeCillis A; Anderson S; J Clin Oncol; 2003 Apr; 21(7):1195-204. PubMed ID: 12663705 [TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer. Calip GS; Malmgren JA; Lee WJ; Schwartz SM; Kaplan HG Breast Cancer Res Treat; 2015 Nov; 154(1):133-43. PubMed ID: 26450505 [TBL] [Abstract][Full Text] [Related]
17. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study. Kaplan H; Malmgren J; De Roos AJ Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844 [TBL] [Abstract][Full Text] [Related]
18. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer. Du XL; Xia R; Liu CC; Cormier JN; Xing Y; Hardy D; Chan W; Burau K Cancer; 2009 Nov; 115(22):5296-308. PubMed ID: 19672997 [TBL] [Abstract][Full Text] [Related]
19. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. Shayne M; Crawford J; Dale DC; Culakova E; Lyman GH; Breast Cancer Res Treat; 2006 Dec; 100(3):255-62. PubMed ID: 16705366 [TBL] [Abstract][Full Text] [Related]
20. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results]. Haase D; Hanf V; Schulz T Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]